Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule

NCT00579410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2011-03-22

No results posted yet for this study

Summary

The purpose of this research is to study the level of acid exposure above the gastroesophageal junction and the distal esophagus in patients with reflux symptoms using a capsule type acid measurement system. Patients with reflux symptoms are likely to have more acid reflux just above the junction of the stomach and the esophagus that may help to improve the diagnosis of gastroesophageal reflux disease (GERD). This may help better treat the reflux symptoms.

Conditions

Sponsors & Collaborators

  • PriCara, Unit of Ortho-McNeil, Inc.

    collaborator INDUSTRY
  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Prateek Sharma, MD · Department of Veterans Affairs Medical Center of Kansas City

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00579410 on ClinicalTrials.gov